HUP0301479A2 - Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállítására - Google Patents
Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállításáraInfo
- Publication number
- HUP0301479A2 HUP0301479A2 HU0301479A HUP0301479A HUP0301479A2 HU P0301479 A2 HUP0301479 A2 HU P0301479A2 HU 0301479 A HU0301479 A HU 0301479A HU P0301479 A HUP0301479 A HU P0301479A HU P0301479 A2 HUP0301479 A2 HU P0301479A2
- Authority
- HU
- Hungary
- Prior art keywords
- cilansetron
- obstipated
- pharmaceutical compositions
- ibs patients
- treating non
- Prior art date
Links
- NCNFDKWULDWJDS-OAHLLOKOSA-N cilansetron Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C=3N4CCCC=3C=CC=2)=C4CC1 NCNFDKWULDWJDS-OAHLLOKOSA-N 0.000 title abstract 2
- 229960002099 cilansetron Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány cilansetron nem-székrekedéses hímnemű IBS-betegekkezelésére szolgáló gyógyszerkészítmények előállítására vonatkozik. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10036645 | 2000-07-26 | ||
DE10123447A DE10123447A1 (de) | 2000-07-26 | 2001-05-14 | Cilansetron enthaltende Arzneimittel zur Behandlung nicht-obstipativer männlicher IBS-Patienten |
PCT/EP2001/008260 WO2002007713A2 (de) | 2000-07-26 | 2001-07-18 | Cilansetron enthaltende arzneimittel zur behandlung nicht-obstipativer männlicher ibs-patienten |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0301479A2 true HUP0301479A2 (hu) | 2003-09-29 |
Family
ID=26006529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301479A HUP0301479A2 (hu) | 2000-07-26 | 2001-07-18 | Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállítására |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1307195A2 (hu) |
JP (1) | JP2004504343A (hu) |
CN (1) | CN1444479A (hu) |
AR (1) | AR028970A1 (hu) |
AU (1) | AU2001276409A1 (hu) |
BR (1) | BR0112690A (hu) |
CA (1) | CA2417677A1 (hu) |
CZ (1) | CZ2003158A3 (hu) |
HU (1) | HUP0301479A2 (hu) |
IL (1) | IL153972A0 (hu) |
MX (1) | MXPA02012917A (hu) |
NO (1) | NO20030373D0 (hu) |
PL (1) | PL363517A1 (hu) |
RU (1) | RU2003104798A (hu) |
SK (1) | SK1272003A3 (hu) |
WO (1) | WO2002007713A2 (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0216027D0 (en) | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
BRPI0503488A (pt) * | 2004-01-30 | 2006-03-07 | Astellas Pharma Inc | agente de tratamento para sìndrome de intestino irritável com diarréia predominante |
WO2005073220A1 (ja) * | 2004-01-30 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | 下痢型過敏性腸症候群治療剤 |
JP4632204B2 (ja) * | 2005-09-21 | 2011-02-16 | アステラス製薬株式会社 | 下痢型過敏性腸症候群治療剤 |
US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
US7601856B2 (en) | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
GB9930077D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
-
2001
- 2001-06-21 AR ARP010102958A patent/AR028970A1/es unknown
- 2001-07-18 WO PCT/EP2001/008260 patent/WO2002007713A2/de not_active Application Discontinuation
- 2001-07-18 RU RU2003104798/15A patent/RU2003104798A/ru not_active Application Discontinuation
- 2001-07-18 JP JP2002513449A patent/JP2004504343A/ja active Pending
- 2001-07-18 IL IL15397201A patent/IL153972A0/xx unknown
- 2001-07-18 EP EP01954044A patent/EP1307195A2/de not_active Withdrawn
- 2001-07-18 CN CN01813307A patent/CN1444479A/zh active Pending
- 2001-07-18 CZ CZ2003158A patent/CZ2003158A3/cs unknown
- 2001-07-18 SK SK127-2003A patent/SK1272003A3/sk unknown
- 2001-07-18 AU AU2001276409A patent/AU2001276409A1/en not_active Abandoned
- 2001-07-18 MX MXPA02012917A patent/MXPA02012917A/es unknown
- 2001-07-18 CA CA002417677A patent/CA2417677A1/en not_active Abandoned
- 2001-07-18 HU HU0301479A patent/HUP0301479A2/hu unknown
- 2001-07-18 PL PL01363517A patent/PL363517A1/xx not_active Application Discontinuation
- 2001-07-18 BR BR0112690-3A patent/BR0112690A/pt not_active Application Discontinuation
-
2003
- 2003-01-24 NO NO20030373A patent/NO20030373D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL363517A1 (en) | 2004-11-29 |
CZ2003158A3 (cs) | 2003-08-13 |
RU2003104798A (ru) | 2004-06-27 |
BR0112690A (pt) | 2003-06-24 |
NO20030373L (no) | 2003-01-24 |
NO20030373D0 (no) | 2003-01-24 |
CN1444479A (zh) | 2003-09-24 |
MXPA02012917A (es) | 2003-05-14 |
AU2001276409A1 (en) | 2002-02-05 |
AR028970A1 (es) | 2003-05-28 |
WO2002007713A2 (de) | 2002-01-31 |
CA2417677A1 (en) | 2003-01-27 |
JP2004504343A (ja) | 2004-02-12 |
SK1272003A3 (en) | 2003-07-01 |
EP1307195A2 (de) | 2003-05-07 |
IL153972A0 (en) | 2003-07-31 |
WO2002007713A3 (de) | 2002-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
ECSP034922A (es) | Pirrolopirimidinas | |
CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
CY1109422T1 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
NO20024005D0 (no) | Pteridinforbindelser for behandling av psoriasis | |
NO20031019L (no) | Vedvarende frigivelsesformuleringer av oksymorfon | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
CY1111396T1 (el) | Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης | |
MXPA04005886A (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6. | |
HUP0302874A2 (hu) | Eljárás risperidon előállítására | |
MXPA03010549A (es) | Formas de dosificacion de oxcarbazepina. | |
HUP0301991A2 (hu) | IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére | |
IL153680A0 (en) | Aplidine derivatives and methods for the preparation thereof | |
HUP0402281A2 (hu) | Endotelin receptor antagonisták alkalmazása daganatos betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
DE60233261D1 (de) | Inhibitoren von humanem adam-10 | |
PT1390371E (pt) | Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores | |
UA83821C2 (ru) | Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли | |
HUP0100080A2 (hu) | Mirtazapin alkalmazása alvásiapnoe kezelésére szolgáló gyógyszerkészítmény előállítására | |
HUP0301479A2 (hu) | Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállítására | |
HUP0203906A2 (en) | Aplidine treatment of cancers | |
MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
SE0004827D0 (sv) | Therapeutic compounds | |
PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
HUP0303181A2 (hu) | 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására |